Healthcare & Life Sciences
Acadia Pharmaceuticals
United Statesacadia.com
Acadia Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Acadia Pharmaceuticals
Acadia Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Acadia Pharmaceuticals develops and commercializes novel therapies for neurological disorders and rare diseases, focusing on treating Parkinson's Disease Psychosis, Rett Syndrome, and Alzheimer's Disease Psychosis.
Explore Acadia Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.